Log in to save to my catalogue

LOXL2 attenuates osteoarthritis through inactivating Integrin/FAK signaling

LOXL2 attenuates osteoarthritis through inactivating Integrin/FAK signaling

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_870554d5f4e14b82a5f20a9dfbb74f3d

LOXL2 attenuates osteoarthritis through inactivating Integrin/FAK signaling

About this item

Full title

LOXL2 attenuates osteoarthritis through inactivating Integrin/FAK signaling

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2021-08, Vol.11 (1), p.17020-17020, Article 17020

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Temporomandibular joint OA (TMJOA) is a common degenerative joint disease, leads to structural damage and ultimately loss of function. Matrix degradation is one of the first pathogenesis during the progression of OA, it was effective to inhibit matrix degradation to block the development of OA. In this study, an in vivo model (compressive mechanica...

Alternative Titles

Full title

LOXL2 attenuates osteoarthritis through inactivating Integrin/FAK signaling

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_870554d5f4e14b82a5f20a9dfbb74f3d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_870554d5f4e14b82a5f20a9dfbb74f3d

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-021-96348-x

How to access this item